THURSDAY 10 JUNE 2010
17:00-18:30 ROUND TABLE: Early lung cancer management
Chairs: M. Agelidou, E. Quoix, D. Misailidou
· (Neo) adjuvant chemotherapy (G. Ostoros)
· Post operative (adjuvant) management (E. Quoix)
· The role of limited resection (G. Stamatis)
· Stereotactic radiotherapy (C. Skarleas)
18:30-18:40 BREAK
18:40-19:50 ROUND TABLE: New approaches in NSCLC treatment
Chairs: R. Pirker, G. Tsoukalas, S. Bousmoukilia
· Optimizing anti-EGFR therapy in NSCLC patients (R. Pirker)
· Antiangiogenic drugs: Where do we stand? (P. Zatloukal)
· Pemetrexed quo Vadis? (K. Syrigos)
20:30 WELCOME RECEPTION
LECTURE
Chair: J-P. Sculier
· The role of chest physicians in lung cancer: from diagnosis to
management (N. Siafakas)
FRIDAY 11 JUNE 2010
08:45-10:00 ROUND TABLE: Fitness for radical treatments in lung cancer
patients
Chairs: J-P. Sculier, V. Georgoulias, A. Charloux
· The ERS algorithm (A. Charloux)
· Surgery (J-P. Sculier)
· Non-surgical treatments (R. Huber)
10:00-10:15 BREAK
10:15-11:30 ROUND TABLE: Customization of NSCLC treatment
Chairs: P. Kosmidis, N. Thatcher, A. Rapti
· According to the stage (chemo± biological agents) (N. Thatcher)
· According to the prognostic and predictive factors (subtypes,
ERCC1, RRM1, TS, etc), (chemo± biological agents) (S. Viteri)
· Stage IIIa: a triple face management (J. Van Meerbeeck)
Moderator: E. Athanasiadis
11:30-11:50 BREAK
11:50-13:30 HOT ISSUES
Chairs: N. Galanis, N. Secen
· 1st and 2nd line therapy in SCLC (R. Huber)
· Mesothelioma (A. Scherpereel)
· Dealing with failure of 1st line therapy in NSCLC
(T. Le Chevalier)
· Prophylactic cranial irradiation (PCI) in extensive small cell lung
cancer (P. Van Houtte)
13:30-14:30 Satellite Symposium “HOT ISSUES IN NSCLC”
Chair: K. Zarogoulidis
· New TNM staging system in NSCLC (A. Rapti)
· State of the Art in NSCLC (K. Syrigos)
17:00-17:40 POSTER SESSION
Chairs: E. Gartzonika, E. Tsarouha, P. Zatloukal
P1 EDUCATION AND PSYCHOSOCIAL ADAPTATION
OF LUNG CANCER PATIENTS
P. Heras, A. Hatzopoulos, M. Hera, M. Mihas, M. Mantzioros, V. Heras, K. Kritikos.
Hellenic Medical Society for the Study of Psychosomatic Problems. Greece.
P2 COPING STYLE AND OUTCOME IN ADVANCED LUNG CANCER PATIENTS
P. Heras, A. Hatzopoulos, M. Mihas, M. Hera, K. Kritikos, M. Mantzioros.
Hellenic Medical Society for the Study of Psychosomatic Problems. Greece.
P3 INITIAL ATTITUDES OF PATIENTS WITH LUNG CANCER (LC) RELATED TO PSYCHOSOCIAL REHABILITATION
P. Heras, A. Hatzopoulos, M. Hera, K. Kritikos, M. Mihas, M. Mantziorros.
Hellenic medical Society for the study of Psychosomatic Problems. Greece.
P4 THE ROLE OF CLINICAL FACTORS AND WHOLE-BODY BONE SCANNING IN DETECTING BONE METASTASES IN PATIENTS WITH LUNG CANCER
D. Tsoukas, A. Kallianos, N. Maniakos, V. Tsagari, S. Karagiannis Ch. Batsakis, E. Gartzonika, A. Rapti
2nd Pulmonology Dept and Nuclear Medicine Dept. Hospital of Chest Diseases of Athens. Greece Hospital.
P5 EASIER TO TREAT AND LESS MALIGNANT IS LUNG CANCER IN WOMEN
A. Kallianos, P. Tsirovasilis, V. Anastasakos, R. Christou, A. Charpidou, J. Giozos, K. Sirigos, A. Rapti
2nd Pulmonology Dept Hospital of Chest Diseases of Athens, Greece
Oncology Unit C University Internal
Medicine, Hospital of Chest Diseases of Athens, Greece.
P6 PHASE II STUDY OF GEMCITABINE PLUS DOCETAXEL AS SECOND-LINE TREATMENT IN MALIGNANT PLEURAL MESOTHELIOMA A SINGLE INSTITUTION STUDY
F. Konstantinou, N. Makrilia, M. Ralli, C. Alamara, G. Tsoukalas, A. Vassias, G. Giozos, S. Tsimpoukis, A. Charpidou
Oncology Unit, Third Department of Medicine, Sotiria General Hospital, Athens School of Medicine.
P7 PHASE II STUDY OF TOPOTECAN PLUS EPIRUBICIN AS SECOND-LINE TREATMENT IN SMALL-CELL LUNG CANCER
C. Roussis1, E. Chondrou1, S. Tsimpoukis1, S. Tsagouli1, D. Vassos1,9, A. Boufas9, I. Danos9, I. Gkiozos1, A. Charpidou1
1 Oncology Unit, 3rd Department of Medicine, Sotiria General Hospital, Athens School of Medicine, Greece.
2 9th Department of Pneumology, Sotiria General Hospital, Athens, Greece.
P8 ADMINISTRATION OF FUNCTIONAL ASSESSMENT OF CANCER-LUNG (FACT-L) QUESTIONNAIRE IN PATIENTS UNDER LUNG CANCER CHEMOTHERAPY AND OBSERVATIONS ON QUALITY OF LIFE AND SURVIVAL. ONGOING STUDY
H. Lithoxopoulou 1, K. Zarogoulidis 1, S. Bostantzopoulou 2,
E. Eleftheriadou1, T. Kontakiotis 3.
1Lung Tumour Research Section, Aristotle University Pulmonary Clinic, ‘G. Papanikolaou’ Hospital, Thessaloniki, Greece
23rd Neurologic Clinic, ‘G. Papanikolaou’ Hospital, Thessaloniki, Greece.
3Bronchoscopic Unit, Aristotle University Pulmonary Clinic, ‘G. Papanikolaou’ Hospital, Thessaloniki, Greece.
C. Fevranoglou1, D. Vassos1, A. Vassias1, E. Gini1, S. Tsagouli1, C. Alamara1, N. Katirtzoglou1, I. Giozos1, A. Charpidou1
Oncology Unit, Third Department of Medicine, Sotiria General Hospital, Athens University School of Medicine, Greece.
P10 Atypical pachypleuritic lesions or atypical bilateral pulmonary embolism? a case report
C. Roussis1, N. Makrilia1, E. Dimakakos1, N. Giatromanolakis1, L. Thanos2, I. Gkiozos1, A. Vassias1, P. Mpoura1, A. Charpidou1
1 Oncology Unit, 3rd Department of Medicine, Athens School of Medicine, Sotiria General Hospital.
2 Imaging and Interventional Radiology Unit, Sotiria General Hospital.
P11 SLEEP QUALITY IN PATIENTS NEWLY DIAGNOSED WITH LUNG CANCER
P. Zarogoulidis1, K. Porpodis1, T. Kontakiotis1, K. Zarogoulidis1, V.
Tsara2
1Lung Tumour Research Section, Aristotle University Pulmonary Clinic, ‘G. Papanikolaou’ Hospital, Thessaloniki, Greece.
2Sleep Unit, G H. ‘G. Papanikolaou’ Hospital, Thessaloniki, Greece.
P12 THE LEVEL OF SURGICAL RESECTIN IN ENDOSCOPICALLY VISIBLE LUNG CANCER CAN BE SIGNIFICANTLY INFLUENCED BY THE AUTOFLUORESCENCE IMAGING VIDEOBRONCHOSCOPY
B. Zaric1, B. Perin1, S. Jovanovic1, E. Budisin1, G. Stojanovic1, N. Lalic1, V. Nisevic1
Institute for Pulmonary Diseases of Vojvodina, Clinic for Pulmonary Oncology, Faculty of Medicine, University of Novi Sad, Serbia.
P13 PROGNOSTIC SIGNIFICANCE OF AUTOPHAGY IN NON-SMALL CELL LUNG CANCER
G. Karpathiou1, A. Giatromanolaki1, M. Koukourakis2, M. Froudarakis3, D. Mikroulis4, D. Bouros3, E. Sivridis1
Departments of 1Pathology, 2Radiotherapy/Oncology, 3Pneumonology, and 4Cardiac/Thoracic Surgery, Democritus University of Thrace Medical School, Alexandroupolis, Greece.
P14 SUBCLAVIAN THROMBOSIS MIMICKING SVCO IN A PATIENT WITH ADVANCED LUNG CANCER – A CASE STUDY
P. Zarogoulidis1, E. Eleftheriadou2, K. Porpodis2, G. Kouliatsis1, J. Pneumatikos1, K. Zarogoulidis 2
1 University Hospital of Alexandroupolis
2 Aristotle University Pulmonary Clinic, ‘G. Papanikolaou’ Hospital, Thessaloniki
17:40-17:50 BREAK
17:50-18:40 LECTURES
Chairs: M. Veslemes, L. Sakas
· The new classification of adenocarcinoma (W. Travis)
· Recent advances in lung cancer staging (E. Canalis)
Moderator: B. Perin
18:40-19:30 ROUND TABLE: Neuro-endocrine lung tumours
Chairs: A. Scherpereel, N. Kerenidi
· Therapy with radio labeled somatostatin analogues in bronchial carcinoids (M. van Essen)
· Long acting somatostatin analogues: any role in SCLC treatment?
(K. Zarogoulidis)
Moderator: A. Charpidou
19:30-19:50 LECTURE
Chair: E. Zachariadis
· Evaluation of bronchoscopic findings in lung cancer
(V. Polychronopoulos)
SATURDAY 12 JUNE 2010
08:15-14:00 Interventional Pulmonology in Thoracic Malignacies
Chairs: M. Froudarakis, S. Gasparini
08:15-08:30 WELCOME
08:30-11:00 MORNING SESSION: Bronchoscopy
· TBNA with or without EBUS? (S. Gasparini)
· Electromagnetic Navigated Bronchoscopy (J. M. Vergnon)
· Which is the best technique for desobstruction (S. Gasparini)
· Treatment of early lesions (J. M. Vergnon)
· Metallic Stents (G. Stratakos)
· Silicon Stents (J. M. Vergnon)
11:30-12:30 BREAK
12:30-14:00 AFTERNOON SESSION: Thoracoscopy
· Thoracoscopy in the undiagnosed pleural effusion (M. Froudarakis)
· Thoracoscopy in mesothelioma (D. Breen)
· Thoracoscopy in the lung cancer staging (M. Froudarakis)
· Thoracoscopy in the treatment of malignant pleural effusion (D. Breen)
14:00 -15:15 ORAL PRESENTATIONS
Chair: V. Ioannidis, P. Zatloukal
O1 SPECTROSCOPY OF TRANSMITTED NIR RADIATION INCREASES SENSITIVITY OF TRANSBRONCHIAL BIOPSY IN SOLITARY PULMONARY NODULES
J. Votruba, T. Brůha, T. Baláž, S. Boris
Nemocnice Na Homolce, Prague, Czech Republic, University of Defense, Brno, Czech Republic.
O2 A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE III INTERGROUP STUDY OF GEFITINIB (G) IN PATIENTS (pts) WITH ADVANCED NSCLC, NON-PROGRESSING AFTER FIRST LINE PLATINUM-BASED CHEMOTHERAPY (EORTC 08021- ILCP 01/03)
J. P. Van Meerbeeck, V. F. Surmont, G. Scagliotti, R. Van Klaveren, D. Papamichael, J. Welch, B. Hasan, V. Torri, R. M. Gaafar.
Ghent University Hospital, Gent, Belgium; University of Turin, Orbassano, Italy; Erasmus MC, Rotterdam, the Netherlands; Bank of Cyprus Oncology Centre, Cyprus; EORTC Head Quarter Brussels Belgium, Istituto di Ricerchi Farmacologiche, Milano, Italy National Cancer Institute, Cairo University, Cairo, Egypt.
O3 FEASIBILITY AND EFFECTIVENESS OF INHALED CARBOPLATIN IN THE TREATMENT OF NSCLC PATIENTS
P. Zarogoulidis1, E. Eleftheriadou2, V. Zarogoulidou2, T. Kontakiotis2, K. Zarogoulidis2
1University Hospital of Alexandroupolis, Greece.
2Aristotle University Pulmonary Clinic, Thessaloniki, Greece.
O4 COMBINATION OF ERLOTINIB AND BEVACIZUMAB IN NSCLC PATIENTS
E. Boutsikou, E. Eleftheriadou, Th. Kontakiotis, P. Zarogoulidis, I. Sapardanis, K. Zarogoulidis
Lung Tumour Research Section, Aristotle University Pulmonary Clinic, ‘G. Papanikolaou’ Hospital, Exohi, Thessaloniki.
O5 EUROPEAN COMPARISONS OF LUNG CANCER MORTALITY IN GREEK POPULATION, ACCORDING TO CIGARETTE CONSUPTION, DURING THE TIME PERIOD 1970-2008
T. C. Constantinidis1,2, P. Zarogoulidis2, M. Orfanidis1,2, K. Zarogoulidis3
1Laboratory of Hygiene and Environmental Protection, Medical School, Democritus University of Thrace, Alexandroupolis, Greece, 2Programm of Postgradued Studies in Health and Safety in Workplaces, Medical School, Democritus University of Thrace, Alexandroupolis, Greece, 3Lung Tumour Research Section, Aristotle University Pulmonary Clinic, ‘G. Papanikolaou’ Hospital, Exohi Thessaloniki, Greece.
O6 CLINICAL SIGNIFICANCE OF SERUM ADIPOKINES LEVELS IN LUNG CANCER
T. Kerenidi1, M. Lada1, A. Tsaroucha1, P. Georgoulias2, P. Mystridou1, K. I. Gourgoulianis1
1Respiratory Department, University Hospital of Larissa, University of Thessaly, Larissa, Greece and 2Department of Nuclear Medicine, University Hospital of Larissa, University of Thessaly, Larissa, Greece.
O7 ADDICTION OF THE NARROW BAND IMAGING (NBI) TO AUTOFLUORESCENCE IMAGING VIDEOBRONCHOSCOPY (AFI) IMPROVES ASSESSMENT OF CENTRAL LUNG CANCER MARGINS.
B. Zaric, B. Perin, S. Jovanovic, E. Budisin, G. Stojanovic, N. Lalic
Institute for Pulmonary Diseases of Vojvodina, Clinic for Pulmonary Oncology, Faculty of Medicine, University of Novi Sad, Serbia
17:00-17:20 LECTURE
Chair: B. Mehic
· Survival analysis in the island of Pythagoras (T. Kontakiotis)
17:20-17:30 BREAK
17:30-19:00 SEMINAR: Organizing a lab for quitting smoking
Coordinator: P. Argyropoulou - Pataka
· Services for smoking cessation the UK experience
(M. Ioannidou)
· Motivating smokers to quit (A. Stefanidou)
· Strategies for smoking cessation (A. Boutou)
· New approaches in pharmacological management
(I. Mitrouska)
SUNDAY 13 JUNE 2010
08:30-18:00 SCHEDULED VISIT TO ANCIENT EPHESSUS